Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.

CDK inhibitors: positive and negative regulators of G1-phase progression

1999 • 6,003 citations

Cancer Cell Cycles

1996 • 5,379 citations

High-efficiency transformation of mammalian cells by plasmid DNA.

1987 • 5,377 citations

The retinoblastoma protein and cell cycle control

1995 • 4,873 citations

β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

1999 • 3,566 citations

New functional activities for the p21 family of CDK inhibitors.

1997 • 1,414 citations

Cyclin A is required at two points in the human cell cycle.

1992 • 1,380 citations

Increasing complexity of Ras signaling

1998 • 1,069 citations

Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes

1998 • 1,058 citations

The Endocrinology and Developmental Biology of the Prostate*

1987 • 1,047 citations

The LNCaP cell line--a new model for studies on human prostatic carcinoma.

1980 • 531 citations

Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling

1996 • 503 citations

Assembly of cyclin D-dependent kinase and titration of p27 ^Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)

1998 • 497 citations

High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21^Cip1

1997 • 464 citations

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

1996 • 421 citations

Antagonistic effect of androgen on prostatic cell death

1984 • 339 citations

The cell cycle and the retinoblastoma protein family

1994 • 309 citations

Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation Sites

1996 • 306 citations

Dual Mechanisms for the Inhibition of E2F Binding to RB by Cyclin-Dependent Kinase-Mediated RB Phosphorylation

1997 • 293 citations

Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G ₁ arrest after γ-irradiation

1999 • 259 citations

The role of the androgen receptor in the development and progression of prostate cancer.

1999 • 245 citations

Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.

1998 • 234 citations

Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.

1991 • 210 citations

Inhibition of DNA synthesis by RB: effects on G₁/S transition and S-phase progression

1998 • 209 citations

Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins

1997 • 206 citations

ras gene mutations in human prostate cancer.

1990 • 202 citations

Multiple G1 Regulatory Elements Control the Androgen-dependent Proliferation of Prostatic Carcinoma Cells

1998 • 197 citations

Activated ras alleles in human carcinoma of the prostate are rare.

1991 • 150 citations

Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis

1994 • 149 citations

Endocrine control of prostate cancer.

1995 • 137 citations

Mammalian G1 cyclins and cell cycle progression.

1995 • 136 citations

Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein

1997 • 131 citations

Rescue of defective mitogenic signaling by D-type cyclins.

1995 • 111 citations

Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.

1999 • 103 citations

Review of the role of androgenic hormones in the epidemiology of benign prostatc hyperplasia and prostate cancer

1994 • 96 citations

Ras Induces Anchorage-Independent Growth by Subverting Multiple Adhesion-Regulated Cell Cycle Events

1996 • 96 citations

Infrequent RAS oncogene mutations in human prostate cancer

1992 • 93 citations

Androgen-regulated gene expression in prostate cancer

1997 • 84 citations

Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells

1999 • 74 citations

D-Type Cyclins and Their Cyclin-dependent Kinases: G1 Phase Integrators of the Mitogenic Response

1994 • 74 citations

Cyclin A Is a Functional Target of Retinoblastoma Tumor Suppressor Protein-mediated Cell Cycle Arrest

1999 • 72 citations

The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death

1999 • 68 citations

v-ras^HExpression Confers Hormone-Independentin VitroGrowth to LNCaP Prostate Carcinoma Cells

1991 • 64 citations

Key Effectors of Signal Transduction and G 1 Progression

1998 • 53 citations

Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.

1998 • 50 citations

Establishment of new human prostatic cancer cell line (JCA-I)

1990 • 49 citations

The retinoblastoma protein is essential for cyclin A repression in quiescent cells

1998 • 40 citations

Mutational Status of Codons 12 and 13 of the N- andK-rasGenes in Tissue and Cell Lines Derived from Primary and Metastatic Prostate Carcinomas

1993 • 39 citations

IncreasedRB1 abnormalities in human primary prostate cancer following combined androgen blockade

1998 • 33 citations

Functional analysis of wild-type and malignant glioma derived CDKN2Aβ alleles: Evidence for an RB-independent growth suppressive pathway

1997 • 32 citations

Treatment Options in Androgen-Independent Prostate Cancer

1999 • 32 citations

Point mutations can inactivate in vitro and in vivo activities of p16INK4a/CDKN2A in human glioma

1997 • 32 citations

Endocrine therapy: where do we stand and where are we going?

1991 • 21 citations